Navigation Links
World first treatment for leukemia being developed in Australia
Date:3/9/2009

Two Australian research groups are undertaking pioneering studies into the causes of leukaemia, potentially leading to patients receiving new drug treatments as early as next year.

Led by Dr Andrew Wei and Professor Shaun Jackson from The Australian Centre for Blood Diseases/Alfred Hospital and Dr Louise Purton and Dr Maria Askmyr from St Vincent's Institute, the groups are among a handful world-wide investigating the impact of the bone marrow microenvironment on leukaemia development and progression a relatively new field of study.

"Armed with our understanding we're planning to be among the first in the world to use the new class of drugs to treat leukaemia patients in 2010" Said Dr Wei.

The Leukaemia Foundation today announced that Dr Wei's and Dr Purton's teams were part of 39 Australian research groups to receive grants in 2009, which were largely funded through donations to the annual World's Greatest Shave, being held this year between 12 14 March.

Leukaemia Foundation of Australia Chief Executive Officer, Peter Cox, said the Foundation funded the best Australian scientists with the best research ideas.

"In 2009, we are funding $3.1 million dollars worth of research nationally."

"The Leukaemia Foundation recognises innovative researchers such as Louise Purton and Andrew Wei think outside the box. They're tackling a new frontier in blood cancer research and we're delighted to be able to support potentially ground-breaking research, particularly if it means Australian patients have access to new treatments sooner," said Mr Cox.

"Some blood cancers, such as leukaemia and myeloma, still have the worst survival rates of any cancer while some of our best treatments are extremely toxic, so it is essential we develop better treatments as well as cures," he said.

"However, we are limited financially in the number of projects we can fund, which is why we encourage Australian's to continue
'/>"/>

Contact: Tiffany Simpson
tsimpson@leukaemia.org.au
61-862-411-010
Research Australia
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Who Lives? to Open at Pico Playhouse on World Kidney Day This Thursday
2. Medco Tops Fortunes Lists of Worlds Most Admired Companies
3. New edition of the Tobacco Atlas catalogues catastrophic toll of tobacco worldwide
4. Drug blocks two of worlds deadliest emerging viruses
5. Drug blocks 2 of worlds deadliest emerging viruses
6. Oxygen4Energy: International Sports News - World Anti-Doping Agency (WADA) Bans Oxygen Use
7. World Television Premiere Event: The Film Pedro Airs on MTV, MTV Tr3s, mtvU & LOGO on Wednesday, April 1 at 8:00 PM ET/PT
8. Ohio Patient Thanks India and WorldMed Assist For Heart Surgery Overseas; His Indian Surgeon Thanks U.S. for Superb Training
9. University of Kansas research finds human emotions hold sway over physical health worldwide
10. Quest Diagnostics Again Named to FORTUNE Magazines Worlds Most Admired Companies List
11. 56-Year-Old Grandmother Heads to Antarctica to Run Her Seventh Worldwide Marathon in Under a Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... bill Medicare for consultations how will they get paid for ... to understand terms. , ... Washington, ... Medicare will eliminate consultation codes. These codes are what ... is seen for a medical consultation, whether in a provider’s ...
(Date:12/15/2009)... America,s premier manufacturer of Spa, Massage, and Medical tables announces ... an adjustable breast comfort system to ease pressure felt while ... ... New Freedom, Pennsylvania (PRWEB) December 15, 2009 -- OAKWORKS®, ... equipment, today announced the launch of the Utopian Massage Table ...
(Date:12/15/2009)... 15 issue of the Journal of Clinical Sleep ... the risk for developing obstructive sleep apnea (OSA) in ... Results indicate that the risk of OSA among Caucasian ... fold with each standard-deviation increase in body mass index ... significantly increase with increasing BMI among younger children. ...
(Date:12/14/2009)... and synthetic red-blood-cell-like particles carry oxygen, drugs, and more… ... ... Scientists at UC Santa Barbara, in collaboration with scientists at ... the characteristics and key functions of natural red blood cells, ... , , , , ,The primary function of natural red ...
(Date:12/14/2009)... LOVELAND, Colo., Dec. 14 Heska ... the "Company"), a leading provider of veterinary ... first customer installation of the Company,s new ... 7000"). ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20000622/HESKALOGO ) ,, ... the fastest multi-patient clinical chemistry analyzer available ...
Breaking Medicine News(10 mins):Health News:Medicare Eliminates Consultation Codes for Doctors 2Health News:Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table 2Health News:Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table 3Health News:Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table 4Health News:Obesity increases the risk for obstructive sleep apnea in adolescents, but not in younger children 2Health News:Synthetic Red Blood Cells Developed 2Health News:Synthetic Red Blood Cells Developed 3Health News:Heska Announces Installation of New Chemistry Analyzer 2Health News:Heska Announces Installation of New Chemistry Analyzer 3
... displacement in the ivyleaf morning glory" , Robin ... , How do we know that interactions between ... abundant evidence to suggest that plant-pollinator interactions influence ... direct evidence that interactions between plant species shape ...
... INDIANAPOLIS, Jan. 4 Eli Lilly and Company,(NYSE: LLY ... and,full year of 2007 on Tuesday, January 29, 2008. Lilly ... investment community and media to,further detail the company,s financial performance., ... to 10:00 a.m. EST.,Investors, media and the general public can ...
... HARRISBURG, Pa., Jan. 4 With the cut of ... some 400 jobs in,Northumberland County and mark the acquisition ... PRWT Services Inc. took over the operation of ... Danville, on Jan. 1. The facility will be,known as ...
... as well with more cost-effective conventional film screenings, study ... results from a landmark trial released in 2005 concluded ... cancers than conventional film mammography was. , But a ... of Internal Medicine , concludes that digital mammography is ...
... get serious about ... health, once and for all, NEW ... and stroke are the nation,s No. 1 and No. 3,killers, claiming ... obese., (Photo: http://www.newscom.com/cgi-bin/prnh/20080104/LAF034 ), World-renowned entertainer Donny Osmond ...
... for 29 categories of awards in the 2007 Association ... Best Monthly Professional Society Magazine as well as the ... winners will be honored at the Salute to Association ... 1996, JBS is the official publication of the Society ...
Other Medicine News:Health News:January American Naturalist highlights 2Health News:January American Naturalist highlights 3Health News:January American Naturalist highlights 4Health News:January American Naturalist highlights 5Health News:January American Naturalist highlights 6Health News:January American Naturalist highlights 7Health News:January American Naturalist highlights 8Health News:January American Naturalist highlights 9Health News:January American Naturalist highlights 10Health News:January American Naturalist highlights 11Health News:January American Naturalist highlights 12Health News:January American Naturalist highlights 13Health News:Not All Women Need Digital Mammograms 2Health News:Donny Osmond, American Heart Association Team Up to Get Americans Walking 2
(Date:12/14/2009)... Dec. 14 Cardium Therapeutics (NYSE Amex: ... 2b Study of GAM501 (Ad5PDGF-B/Collagen) in the Treatment ... Healing: Science and Industry Conference held December 10-13, ... The conference is attended by top industry leaders ... wound healing. Dr. Barbara K. Sosnowski, Cardium,s ...
(Date:12/14/2009)... SKIPPACK, Pa., Dec. 14 At GeoInvesting.com, we ... ) for some time now. Our largest hang up ... Although the Company,s fiscal June 2010 net income guidance ... fiscal 2009 reported net income of $7.9 million, the ... term EPS growth scenario, which depends upon the share ...
(Date:12/14/2009)... HELSINKI, Dec. 14 Cancer patients in ... with the introduction of RapidArc® radiotherapy technology from ... at the only private radiotherapy clinic in the ... are using this fast and precise form of ... and cancers of the abdomen and prostate. ,, ...
Breaking Medicine Technology:Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development 2Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development 3Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development 4GeoInvesting.com Offers Insight Into Two Growing Chinese Pharmaceutical Firms 2Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 2Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 3Time to Turn the Town Pink 57587 1Time to Turn the Town Pink 57587 2Dey L P Settles State of Utah Pricing Litigation 57583 1Dey L P Settles State of Utah Pricing Litigation 57583 2The Lustgarten Foundation Expresses Condolences as Pancreatic Cancer Claims Life of Myles Brand 57580 1
... - ORENCIA is a First-in-Class Biologic Treatment Option Now Available ... Use in Pediatric Patients with ... Company (NYSE: BMY ) today announced that the U.S. ... signs,and symptoms in pediatric patients six years and older with ...
... Inc. (Nasdaq: ARNA ) announced today that ... of APD125 in patients with primary,insomnia. APD125 is ... the,potential to reduce insomnia symptoms and improve sleep ... APD125 is a double-blind, randomized, placebo-,controlled subjective study ...
Other Medicine Technology:U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 2U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 3U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 4U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 5U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 6U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 7U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 8U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 9U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 10Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia 2Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia 3Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia 4Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia 5
...
...
...
Tip is bent towards port for downward irrigation. 25G x 7/8in (.50 x 16mm)...
Medicine Products: